{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:16:55Z","timestamp":1791483415611,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T00:00:00Z","timestamp":1437696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/cgt.2015.31","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T10:20:57Z","timestamp":1437733257000},"page":"387-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines"],"prefix":"10.1038","volume":"22","author":[{"given":"H-A","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N-Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"BFcgt201531_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jcb.20828","volume":"98","author":"ME Ramos\u2010Nino","year":"2006","unstructured":"Ramos\u2010Nino ME, Testa JR, Altomare DA, Pass HI, Carbone M, Bocchetta M et al. Cellular and molecular parameters of mesothelioma. J Cell Biochem 2006; 98: 723\u2013734.","journal-title":"J Cell Biochem"},{"key":"BFcgt201531_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/aje\/kwh025","volume":"159","author":"B Price","year":"2004","unstructured":"Price B, Ware A . Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004; 159: 107\u2013112.","journal-title":"Am J Epidemiol"},{"key":"BFcgt201531_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1265\/jjh.63.739","volume":"63","author":"A Hirose","year":"2008","unstructured":"Hirose A, Hirano S . [Health effects of nanoparticles and nanomaterials (III). Toxicity and health effects of nanoparticles]. Nihon Eiseigaku Zasshi 2008; 63: 739\u2013745.","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"BFcgt201531_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncponc1039","volume":"5","author":"DA Fennell","year":"2008","unstructured":"Fennell DA, Gaudino G, O'Byrne KJ, Mutti L, Van Meerbeeck J . Advances in the systemic therapy of malignant pleural mesothelioma. Nat Clin Pract Oncol 2008; 5: 136\u2013147.","journal-title":"Nat Clin Pract Oncol"},{"key":"BFcgt201531_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.hoc.2005.09.012","volume":"19","author":"E Pisick","year":"2005","unstructured":"Pisick E, Salgia R . Molecular biology of malignant mesothelioma: a review. Hematol Oncol Clin North Am 2005; 19: 997\u20131023.","journal-title":"Hematol Oncol Clin North Am"},{"key":"BFcgt201531_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev.cellbio.22.010305.104154","volume":"23","author":"NA Lobo","year":"2007","unstructured":"Lobo NA, Shimono Y, Qian D, Clarke MF . The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007; 23: 675\u2013699.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFcgt201531_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1582-4934.2007.00211.x","volume":"12","author":"AK Croker","year":"2008","unstructured":"Croker AK, Allan AL . Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 2008; 12: 374\u2013390.","journal-title":"J Cell Mol Med"},{"key":"BFcgt201531_CR8","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.devcel.2008.11.010","volume":"15","author":"J Jiang","year":"2008","unstructured":"Jiang J, Hui C-c . Hedgehog signaling in development and cancer. Dev Cell 2008; 15: 801\u2013812.","journal-title":"Dev Cell"},{"key":"BFcgt201531_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4161\/cbt.5.6.2906","volume":"5","author":"S Mukherjee","year":"2006","unstructured":"Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP et al. Research paper hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 2006; 5: 674\u2013683.","journal-title":"Cancer Biol Ther"},{"key":"BFcgt201531_CR10","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1016\/j.bmc.2008.01.012","volume":"16","author":"SK Kumar","year":"2008","unstructured":"Kumar SK, Roy I, Anchoori RK, Fazli S, Maitra A, Beachy PA et al. Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer. Bioorg Med Chem 2008; 16: 2764\u20132768.","journal-title":"Bioorg Med Chem"},{"key":"BFcgt201531_CR11","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1038\/onc.2011.195","volume":"30","author":"RR Singh","year":"2011","unstructured":"Singh RR, Kunkalla K, Qu C, Schlette E, Neelapu SS, Samaniego F et al. ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 2011; 30: 4874\u20134886.","journal-title":"Oncogene"},{"key":"BFcgt201531_CR12","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","volume":"18","author":"Y Shi","year":"2012","unstructured":"Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, Thies S et al. Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res 2012; 18: 4646\u20134656.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201531_CR13","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","volume":"66","author":"S Liu","year":"2006","unstructured":"Liu S, Dontu G, Mantle ID, Patel S, Ahn N-s, Jackson KW et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006; 66: 6063\u20136071.","journal-title":"Cancer Res"},{"key":"BFcgt201531_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.lungcan.2010.04.020","volume":"70","author":"K Kai","year":"2010","unstructured":"Kai K, D\u2019Costa S, Yoon B-I, Brody AR, Sills RC, Kim Y . Characterization of side population cells in human malignant mesothelioma cell lines. Lung Cancer 2010; 70: 146\u2013151.","journal-title":"Lung Cancer"},{"key":"BFcgt201531_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2008.12.023","volume":"278","author":"K Kai","year":"2009","unstructured":"Kai K, D\u2019Costa S, Sills RC, Kim Y . Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines. Cancer Lett 2009; 278: 49\u201355.","journal-title":"Cancer Lett"},{"key":"BFcgt201531_CR16","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/cancers3021744","volume":"3","author":"LY Pang","year":"2011","unstructured":"Pang LY, Cervantes-Arias A, Else RW, Argyle DJ . Canine mammary cancer stem cells are radio-and chemo-resistant and exhibit an epithelial-mesenchymal transition phenotype. Cancers 2011; 3: 1744\u20131762.","journal-title":"Cancers"},{"key":"BFcgt201531_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.taap.2005.12.009","volume":"214","author":"Y Kim","year":"2006","unstructured":"Kim Y, Ton T-V, DeAngelo AB, Morgan K, Devereux TR, Anna C et al. Major carcinogenic pathways identified by gene expression analysis of peritoneal mesotheliomas following chemical treatment in F344 rats. Toxicol Appl Pharmacol 2006; 214: 144\u2013151.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFcgt201531_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.canlet.2007.05.006","volume":"255","author":"RJ Levitt","year":"2007","unstructured":"Levitt RJ, Zhao Y, Blouin M-J, Pollak M . The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells. Cancer Lett 2007; 255: 300\u2013306.","journal-title":"Cancer Lett"},{"key":"BFcgt201531_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C . A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995; 184: 39\u201351.","journal-title":"J Immunol Methods"},{"key":"BFcgt201531_CR20","doi-asserted-by":"publisher","first-page":"e57346","DOI":"10.1371\/journal.pone.0057346","volume":"8","author":"H Li","year":"2013","unstructured":"Li H, Lui N, Cheng T, Tseng H-HK, Yue D, Giroux-Leprieur E et al. Gli as a novel therapeutic target in malignant pleural mesothelioma. PloS One 2013; 8: e57346.","journal-title":"PloS One"},{"key":"BFcgt201531_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/onc.2009.392","volume":"29","author":"L Yang","year":"2009","unstructured":"Yang L, Xie G, Fan Q, Xie J . Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2009; 29: 469\u2013481.","journal-title":"Oncogene"},{"key":"BFcgt201531_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jtcvs.2013.08.035","volume":"147","author":"M You","year":"2014","unstructured":"You M, Varona-Santos J, Singh S, Robbins DJ, Savaraj N, Nguyen DM . Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. J Thorac Cardiovasc Surg 2014; 147: 508\u2013516.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BFcgt201531_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","volume":"71","author":"S B\u00f6l\u00fckbas","year":"2011","unstructured":"B\u00f6l\u00fckbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J . Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy. Lung Cancer 2011; 71: 75\u201381.","journal-title":"Lung Cancer"},{"key":"BFcgt201531_CR24","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH . Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265\u20137279.","journal-title":"Oncogene"},{"key":"BFcgt201531_CR25","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s004320050222","volume":"124","author":"M Mitsumoto","year":"1998","unstructured":"Mitsumoto M, Kamura T, Kobayashi H, Sonoda T, Kaku T, Nakano H . Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice. J Cancer Res Clin Oncol 1998; 124: 607\u2013614.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFcgt201531_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/path.1810","volume":"207","author":"X Sun","year":"2005","unstructured":"Sun X, Wei L, Lid\u00e9n J, Hui G, Dahlman\u2010Wright K, Hjerpe A et al. Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. J Pathol 2005; 207: 91\u2013101.","journal-title":"J Pathol"},{"key":"BFcgt201531_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-012-1493-6","volume":"373","author":"S-H Li","year":"2013","unstructured":"Li S-H, Fu J, Watkins DN, Srivastava RK, Shankar S . Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog\u2013GLI pathway. Mol Cell Biochem 2013; 373: 217\u2013227.","journal-title":"Mol Cell Biochem"},{"key":"BFcgt201531_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"Pollak MN, Schernhammer ES, Hankinson SE . Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004; 4: 505\u2013518.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt201531_CR29","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1073\/pnas.0504337103","volume":"103","author":"NA Riob\u00f3","year":"2006","unstructured":"Riob\u00f3 NA, Lu K, Ai X, Haines GM, Emerson CP . Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc Natl Acad Sci USA 2006; 103: 4505\u20134510.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cgt201531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201531","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:14:08Z","timestamp":1684415648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFcgt201531"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2015.31","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]},"assertion":[{"value":"23 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}